Tag Archives: Patient Navigator Program

ACC Completes Hospital Selection in Their Innovative Patient Navigator Program

AZ1525_screenx

TPNP Logo Graphic_High Reshe American College of Cardiology (ACC) has announced that 20 hospitals from across the country have been selected to participate in the ACC Patient Navigator Program, rounding out the 35 total hospitals in the program.

This innovative initiative, which has already launched in 15 hospitals, is designed to provide participating hospitals with training and resources to establish navigator teams charged with coordinating personalized support for patients diagnosed with acute coronary syndrome (ACS), including heart attack, and heart failure (HF) during their hospital stay and in the weeks following their discharge when they are most vulnerable.

AstraZeneca is proud to be the Founding Sponsor to support this ACC initiative. We are the first company to provide large-scale funding for this type of national, cardio-focused patient navigator program.

“It is an exciting milestone to see all 35 hospitals enrolled in the ACC Patient Navigator Program because now more patients and caregivers will have access to the support and services provided by the Patient Navigator teams in hospitals across the country,” said Gregory F. Keenan, M.D., Vice President and U.S. Head Medical Officer, AstraZeneca. “At AstraZeneca, we know that cardiovascular disease impacts each patient differently, and the needs of patients and caregivers are distinct and personal following a heart attack. That’s why we’re proud to be the founding sponsor of this program, and our hope is that supporting initiatives like this can help make a meaningful difference for patients and their families.”

According to the ACC, they have carefully chosen a diverse group of hospitals from across the country to participate in their program, representing a broad patient population and hospital treatment approaches to cardiac care.

The 20 newly selected hospitals include:

  • Aurora BayCare Medical Center, Green Bay, WI
  • Baptist Health Louisville, Louisville, KY
  • Barnes-Jewish Hospital at Washington University Medical Center, St. Louis, MO
  • California Pacific Medical Center, San Francisco, CA
  • Centra Lynchburg General Hospital, Lynchburg, VA
  • Fairview Hospital, Cleveland, OH
  • Indian River Medical Center, Vero Beach, FL
  • Mercy Hospital, Portland, ME
  • Mercy Medical Center, Des Moines, IA
  • Newark Beth Israel Medical Center, Newark, NJ
  • Olathe Medical Center, Olathe, KS
  • Renown Regional Medical Center, Reno, NV
  • Vincent’s Medical Center, Bridgeport, CT
  • Tacoma General Hospital, Tacoma, WA
  • University of Colorado Hospital, Aurora, CO
  • University of Utah, Salt Lake City, UT
  • UT Southwestern Medical Center, Dallas, TX
  • West Jefferson Medical Center, Marrero, LA
  • Western Maryland Health System, Cumberland, MD
  • Wyoming Medical Center, Casper, WY

The 15 previously selected hospitals include:

  • Advocate Sherman Hospital, Elgin, IL
  • Christiana Care Health Services, Wilmington, DE
  • Einstein Medical Center Philadelphia, Philadelphia, PA
  • Indiana University Health Methodist Hospital, Indianapolis, IN
  • MedStar Washington Hospital Center, Washington, DC
  • Providence St. Vincent Medical Center, Portland, OR
  • Ronald Reagan UCLA Medical Center, Los Angeles, CA
  • Mary’s Hospital, Waterbury, CT
  • Trident Health, Charleston, SC
  • Vanderbilt Heart and Vascular Institute, Nashville, TN
  • WakeMed Health and Hospital, Raleigh, NC
  • Scott & White Healthcare, Temple, TX
  • VCU Pauley Heart Center VCU Medical Center, Richmond, VA
  • Montefiore Medical Center, New York, NY
  • Huntsville Hospital, Huntsville, AL

As cardiovascular leaders, this program aligns with AstraZeneca’s commitment to patients and finding novel approaches to improving cardiovascular care.

MedStar Official Addresses Importance of ACC Patient Navigator Program

By Dr. Stuart F. Seides, Physician Executive Director at MedStar Heart Institute

From left: Dr. Allen Taylor, Chief of Cardiology at MedStar Heart Institute; Rich Buckley, VP Corporate Affairs North America, AstraZeneca; Shal Jacobovitz, CEO of the American College of Cardiology; Dr. Stuart Seides, Chief Executive at MedStar Heart Institute

From left: Dr. Allen Taylor, Chief of Cardiology at MedStar Heart Institute; Rich Buckley, VP Corporate Affairs North America, AstraZeneca; Shal Jacobovitz, CEO of the American College of Cardiology; Dr. Stuart Seides, Chief Executive at MedStar Heart Institute

As the Physician Executive Director at MedStar Heart Institute in Washington, D.C., it is my responsibility to ensure that we provide patients with the best in cardiac care. From the moment patients arrive, through their treatment, discharge and then follow-up care—the MedStar Heart Institute strives to provide a seamless continuum of services.

Several weeks ago, I attended an event at MedStar Washington Hospital Center to celebrate the launch of the American College of Cardiology (ACC) Patient Navigator Program, sponsored by AstraZeneca. The program provides personalized support to heart attack and heart failure patients as they transition from hospital to home, which is vital because cardiovascular disease impacts every patient differently.

The ACC Patient Navigator Program truly puts cardiovascular patients and their caregivers first as they discharge from the hospital—a process that can be confusing and overwhelming for many. I commend the ACC and AstraZeneca for working together to bring this innovative program to my hospital, and I look forward to sharing the results with my peers.

Dr. Stuart F. Seides is the Physician Executive Director at MedStar Heart Institute, one of the highest volume heart care programs in the United States. Dr. Seides is an interventional cardiologist, practicing in Washington, D.C. since 1978.

PNP Logo Graphic

MedStar Logo

MedStar Washington Hospital Center Becomes First to Launch ACC Patient Navigator Program

MedStar Washington Hospital Center in Washington, D.C. became the first hospital to provide cardiology patients with support through the American College of Cardiology (ACC) Patient Navigator Program, sponsored by AstraZeneca. MedStar Washington Hospital Center is one of 35 hospitals across the country that will participate between now and the end of 2015. Thus far, 11 hospitals have been selected to take part in the ACC program, which provides enhanced support for cardiology patients as they transition from hospital to home following their heart attack.

The ACC Patient Navigator Program will provide personalized support to patients with acute coronary syndrome (ACS) based on their specific needs, which is vital because cardiovascular disease impacts every patient differently. The program will support patients with ACS as they face physical, emotional and other issues after having a heart attack. According to the ACC, one of the goals is to make ACS patients’ hospitalization less stressful and the recovery period more supportive.

AstraZeneca’s sponsorship of the ACC Patient Navigator Program aligns with our commitment to putting patients at the core of everything we do and to helping health care professionals support their patients with cardiovascular diseases.   Read more about AstraZeneca’s sponsorship of the ACC Patient Navigator Program.

DID YOU KNOW?

In a recent study of Medicare patients discharged after a heart attack, 25.9 percent of heart attack patients died and 50.5 percent were re-hospitalized within the first year.

– Dharmarajan K; Hsieh AF; Lin Z et al. Abstract 13: Risks of Death and Hospital Readmission by Time Following Hospitalization for Heart Failure and Acute Myocardial Infarction. Circ Cardiovasc Qual Outcomes. 2013; 6: A13.

2939301 12/13

American College of Cardiology Announces First Hospitals to Participate in the Patient Navigator Program

PNP Logo Graphic for Blog and Intranet Article 120312Patients with Acute Coronary Syndrome (ACS) face many difficulties as they transition from the hospital back to their home following a cardiovascular event. It is critical they understand at discharge the next steps in their road to recovery.

A recent JAMA Internal Medicine study looked at transitional care after hospitalization and found that a fourth of discharge instructions were written in medical jargon that a patient was not likely to understand.

AstraZeneca became the founding sponsor of the American College of Cardiology (ACC) Patient Navigator Program, contributing $10 million to this program earlier this year. The program was designed to help cardiology patients through the challenges of transitioning from hospital to home following their heart attack.

Today, the ACC announced the first hospitals selected to be a part of its program:

The ACC Patient Navigator Program will provide personalized support to patients with ACS at these hospitals based on their specific needs, which is vital because cardiovascular disease impacts every patient differently.

The ACC Patient Navigator Program aligns with AstraZeneca’s desire to put patients at the core of everything we do and our commitment to finding new ways to support patients’ health.

 

2913305 Last Updated 12/13